Dermatitis: Clinical Trials

18 trials for Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 withdrawn. 18 Phase 2, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 218Withdrawn 18
Phase 16Withdrawn 6

Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
Ivermectin Pill - Atopic Dermatitis
Phase 2WithdrawnStanford University2030-12-012024-12-02
Topical Steroids & Bacterial Decolonization for Radiation Dermatitis
Bacterial decolonization, Mometasone furoate 0.1% cream, Bacterial decolonization and Mometasone furoate 0.1% cream - Radiation Dermatitis
Phase 2WithdrawnMontefiore Medical Center2023-09-012023-12-22
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
Naltrexone, Placebo - Atopic Dermatitis, Pruritus
Phase 2WithdrawnUniversity of Minnesota2022-12-312023-04-04
A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis
BX005-A, Placebo - Atopic Dermatitis
Phase 1 / Phase 2WithdrawnBiomX, Inc.2022-05-012025-08-03
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
Naltrexone, Placebo Cream - Atopic Dermatitis, Pruritus
Phase 2WithdrawnUniversity of Minnesota2020-10-012021-04-20
Moisturizer to Prevent Atopic Dermatitis
Cura+ Moisturizing Cream - Dermatitis, Atopic
Phase 2WithdrawnMYOR Ltd.2020-06-012021-01-15
Very Small Embryonic-like Stem Cells for Facial Skin Antiaging
Very small embryonic-like stem cell - Stem Cell Transplant Complications, Skin Inflammation
Phase 1 / Phase 2WithdrawnFuda Cancer Hospital, Guangzhou2019-07-062020-10-19
A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
SAN007 Cream, Placebo - Atopic Dermatitis
Phase 2WithdrawnSantalis Pharmaceuticals, Inc.2018-06-012019-01-17
A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis
Orvepitant, Placebo - Pruritus, Atopic Dermatitis
Phase 2WithdrawnNerre Therapeutics Ltd.2018-05-012018-05-15
Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Clobetasol 0.05% ointment, Placebo - Toxic Epidermal Necrolysis
Phase 1 / Phase 2WithdrawnUniversity of California, Davis2016-11-012019-08-09
Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
Moisturizer with each subject's own antimicrobial bacteria - Atopic Dermatitis, Eczema
Phase 2WithdrawnUniversity of California, San Diego2015-07-012020-11-05
Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome
Phase 1 / Phase 2WithdrawnJames Chodosh, MD, MPH2014-11-012017-04-07
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Solar Protection Formula SPF® 60, Photobiological testing - High-grade Dysplasia in Barrett Esophagus, Non Small Cell Lung Cancer
Phase 2WithdrawnPinnacle Biologics Inc.2013-05-012014-03-04
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
Norepinephrine - Radiodermatitis
Phase 1 / Phase 2WithdrawnProCertus BioPharm, Inc2012-03-012012-05-28
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Infliximab - Stevens-Johnson Syndrome, Corneal Blindness
Phase 1 / Phase 2WithdrawnMassachusetts Eye and Ear Infirmary2010-12-012015-11-04
Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome
henna paste - Hand Foot Skin Syndrome
Phase 2WithdrawnNorthwestern University2010-03-012014-12-12
A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)
Roflumilast cream, Placebo cream - Dermatitis
Phase 2WithdrawnAstraZeneca2008-11-012016-12-01
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Remicaide (infliximab) - Toxic Epidermal Necrolysis
Phase 2WithdrawnLoyola University2006-07-012013-04-26

Narrower conditions

Dermatitis, Atopic (8)  ·  Stevens-Johnson Syndrome (4)  ·  Pruritus (3)  ·  Eczema (2)  ·  Radiodermatitis (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Dermatitis, Phototoxic (1)  ·  Esophageal Neoplasms (1)  ·  Hand-Foot Syndrome (1)  ·  Pemphigoid, Benign Mucous Membrane (1)  ·  Syndrome (1)

Broader conditions

Skin Diseases (18)  ·  Skin and Connective Tissue Diseases (18)  ·  Hypersensitivity (12)  ·  Immune System Diseases (12)  ·  Skin Diseases, Eczematous (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8)  ·  Genetic Diseases, Inborn (8)  ·  Hypersensitivity, Immediate (8)  ·  Skin Diseases, Genetic (8)  ·  Chemically-Induced Disorders (5)  ·  Drug Eruptions (5)  ·  Drug Hypersensitivity (5)  ·  Drug-Related Side Effects and Adverse Reactions (5)  ·  Erythema (4)

Interventions

Infliximab (3)  ·  Naltrexone (2)  ·  Clobetasol (1)  ·  Exercise (1)  ·  Ivermectin (1)  ·  Mometasone Furoate (1)  ·  Norepinephrine (1)  ·  Ointments (1)  ·  orvepitant (1)

Sponsors

University of Minnesota (2)  ·  AstraZeneca (1)  ·  BiomX, Inc. (1)  ·  Fuda Cancer Hospital, Guangzhou (1)  ·  James Chodosh, MD, MPH (1)  ·  Loyola University (1)  ·  MYOR Ltd. (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Montefiore Medical Center (1)  ·  Nerre Therapeutics Ltd. (1)  ·  Northwestern University (1)  ·  Pinnacle Biologics Inc. (1)  ·  ProCertus BioPharm, Inc (1)  ·  Santalis Pharmaceuticals, Inc. (1)  ·  Stanford University (1)

Countries

United States (9)  ·  Canada (1)  ·  China (1)

Top investigators

James Chodosh, MD, MPH (2)  ·  Paul Bigliardi, MD (2)  ·  Claes H Dohlman, MD, PhD (1)  ·  Eleanor Harris, MD (1)  ·  Elena Fridman, MD (1)  ·  Emanual Maverakis, MD (1)  ·  Kavita Sarin, MD, PhD (1)  ·  Lindsay Pattison (1)  ·  Mona Harissi-Dagher, MD (1)  ·  Peter Lio, MD (1)  ·  Richard Gamelli, MD (1)  ·  Richard L Gallo, MD, PhD (1)  ·  Urania Rappo, MD (1)  ·  Yana Kost (1)

Results publications

PMID 26297574